•
Mar 31, 2021

DaVita Q1 2021 Earnings Report

Announced financial and operating results for the quarter ended March 31, 2021.

Key Takeaways

DaVita Inc. reported Q1 2021 results with a diluted EPS of $2.09, a 15.5% increase from the prior year. Consolidated revenues reached $2.820 billion, and operating income was $443 million. The company faced COVID-19 related challenges, impacting operating income by an estimated $(35) million.

Consolidated revenues were $2.820 billion.

Operating income was $443 million.

Diluted earnings per share was $2.09.

Operating cash flow and free cash flow were $154 million and $(17) million, respectively.

Total Revenue
$2.82B
Previous year: $2.84B
-0.7%
EPS
$2.09
Previous year: $1.83
+14.2%
US Dialysis Treatments
7.29M
Previous year: 7.51M
-3.0%
US Avg Treatments per day
94.64K
Previous year: 96.82K
-2.3%
US Revenue per Treatment
$355
Previous year: $348
+2.0%
Gross Profit
$882M
Previous year: $866M
+1.8%
Cash and Equivalents
$884M
Previous year: $1.38B
-36.0%
Free Cash Flow
-$17M
Previous year: $184M
-109.2%
Total Assets
$17.6B
Previous year: $17.6B
+0.3%

DaVita

DaVita

DaVita Revenue by Segment

DaVita Revenue by Geographic Location

Forward Guidance

DaVita provided its 2021 guidance. Adjusted operating income is expected to be between $1,750 million and $1,875 million. Adjusted diluted net income from continuing operations per share attributable to DaVita Inc. is projected to be $8.20 to $9.00. Free cash flow from continuing operations is expected to range from $900 million to $1,150 million.

Positive Outlook

  • Adjusted operating income between $1,750 and $1,875 million
  • Adjusted diluted net income from continuing operations per share between $8.20 and $9.00
  • Free cash flow from continuing operations between $900 and $1,150 million

Revenue & Expenses

Visualization of income flow from segment revenue to net income